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Leishmania donovani is a protozoan parasite that causes
visceral leishmaniasis, a devastating and often fatal disease in
humans. The parasite exhibits a digenetic life cycle; the extracellular, flagellated, and motile promastigote that resides
within the insect vector, members of the phlebotomine sandfly
family, and the intracellular, aflagellar, and nonmotile
amastigote that exists within the phagolysosome of macrophages and other reticuloendothelial cells of the infected mammalian host. The drugs used to treat visceral leishmaniasis
have been empirically derived and are toxic, require prolonged
and multiple administrations, and are often ineffective. The
toxicity can be ascribed to the lack of target specificity within
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the parasite. Thus, the need for more efficacious and specific
drugs is acute.
The design of selective antiparasitic drugs depends on the
exploitation of fundamental biochemical differences between
parasite and host. Perhaps the most remarkable metabolic
discrepancy between protozoan parasites and their human host
is that the former are incapable of synthesizing the purine ring
de novo (1). Thus, all protozoan parasites studied to date have
evolved a unique series of purine salvage enzymes that enable
parasites to scavenge purines from their host. Purine acquisition by the parasite is initiated by the translocation of extracellular purines across the parasite cell surface membranes, a
process that is mediated by nutritionally indispensable nucleoside and nucleobase transporters.
Genetic and biochemical investigations (2, 3) have demonstrated that L. donovani express two nucleoside transporter
activities of nonoverlapping ligand specificities; LdNT1, which
recognizes adenosine and pyrimidine nucleosides, and LdNT2,
which mediates the transport of inosine and guanosine. Subsequently, the genes encoding LdNT1 (4) and LdNT2 (5) were
isolated by functional rescue of nucleoside transport-deficient
L. donovani. The LdNT1 locus encompasses two closely related
genes, LdNT1.1 and LdNT1.2, and although both are functional after expression in either Xenopus laevis oocytes or
L. donovani, only LdNT1.1 transcript is detected by Northern
blot analysis of promastigote mRNA (6). Predicted amino acid
sequences and membrane topologies of LdNT1.1, LdNT1.2, and
LdNT2 reveal that all three transporter proteins are members
of the equilibrative nucleoside transporter (ENT)1 family (7).
Mammalian cells and other eukaryotes also express a battery
of ENTs, as well as sodium-dependent concentrative nucleoside
transporters, which are unrelated in sequence to the ENTs (8).
Leishmania parasites maintain a large proton electrochemical gradient across the plasma membrane with a resting potential near ⫺100 mV (9, 10), and it has been conjectured that
these organisms generally exploit this electrochemical gradient
to drive concentrative uptake of nutrients into the parasite
(11). One example of proton driven transport emerged from
studies on the proton/myo-inositol co-transporter of L. donovani (12, 13). In order to determine whether nucleoside uptake
into Leishmania could utilize this proton gradient, LdNT1.1,
LdNT1.2, and LdNT2 cRNAs were expressed into X. laevis
oocytes. Two-electrode voltage clamp measurements on these
oocytes revealed that all three carriers were electrogenic. It
was further shown that LdNT1.1 and LdNT1.2 mediate two
1
The abbreviations used are: ENT, equilibrative nucleoside transporter; DPA, dipyridamole; Imax, maximum current; pC, picoCoulombs;
RMP, resting membrane potential; TMD, transmembrane domain; Vm,
membrane potential; Vmax, maximum transport velocity; Vrev, reversal
potential; MES, 2-(N-morpholino)ethan sulfonic acid.
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Leishmania donovani express two members of the
equilibrative nucleoside transporter family; LdNT1 encoded by two closely related and linked genes, LdNT1.1
and LdNT1.2, that transport adenosine and pyrimidine
nucleosides and LdNT2 that transports inosine and
guanosine exclusively. LdNT1.1, LdNT1.2, and LdNT2
have been expressed in Xenopus laevis oocytes and
found to be electrogenic in the presence of nucleoside
ligands for which they mediate transport. Further
analysis revealed that ligand uptake and transport currents through LdNT1-type transporters are proton-dependent. In addition to the flux of protons that is coupled to the transport reaction, LdNT1 transporters
mediate a variable constitutive proton conductance that
is blocked by substrates and dipyridamole. Surprisingly, LdNT1.1 and LdNT1.2 exhibit different electrogenic properties, despite their close sequence homology.
This electrophysiological study provides the first demonstration that members of the equilibrative nucleoside
transporter family can be electrogenic and establishes
that these three permeases, unlike their mammalian
counterparts, are probably concentrative rather than
facilitative transporters.
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pharmacologically separable ion permeation mechanisms, a
proton-dependent, inwardly rectifying transport current, and a
tonic, linear, and reversible current carried by protons, respectively. From these results, we conclude that these three nucleoside permeases are likely concentrative proton symporters
and that some members of the ENT family are thus active
transporters.
EXPERIMENTAL PROCEDURES

Nucleoside Transporter cRNA Expression in Oocytes—Defolliculated
stage V-VI X. laevis oocytes were microinjected with ⬃50 ng of capped
mRNA that was transcribed with T7 RNA polymerase (Invitrogen) from
linearized pL2–5 plasmids (14) containing either LdNT1.1, LdNT1.2, or
LdNT2 using a nanoliter injector from World Precision Instruments
(Sarasota, FL). Oocytes were stored at 16 °C in frog Ringer’s solution
containing 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM
Na-HEPES, pH 7.5, and 1.5% heat-inactivated horse serum. Electrophysiological and radiolabel uptake measurements were performed 4 –7
days after cRNA injection.
Electrophysiological Recording—Unless otherwise indicated, recording solutions contained 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM
MgCl2, and a buffer of either 10 mM HEPES-Tris, pH 7.5, 10 mM
MES-Tris, pH 5.5, 10 mM MES-Tris, pH 6.5, or 10 mM Tris-HEPES, pH
8.5. In experiments where Na⫹ was varied or replaced, equimolar
concentrations of choline were substituted for the Na⫹. Two microelectrode voltage-clamp recordings were performed at room temperature
using a Gene Clamp 500 interfaced to an IBM compatible PC-AT using
a Digidata 1200 A/D controlled by the pCLAMP program suite (version
6.0.3; Axon Instruments). A MacLab/2e analog/digital converter (AD-

Instruments) was used to continuously monitor currents. Microelectrodes were filled with a 3 M KCl solution and had resistances of less
than 1.5 M⍀. Substrates and antagonists were introduced by gravity
flow into a bath that was continuously perfused with Ringer’s solution.
Dipyridamole (DPA) was dissolved in 0.1% Me2SO, which did not induce a current itself in either LdNT-injected or uninjected oocytes (data
not shown). Current-voltage measurements were made during 250-ms
voltage pulses to a series of command potentials. Current data were
digitized at 1 kHz. The normalized mean concentration response of
currents induced by substrate was fitted by least squares to the Michaelis-Menten equation: I ⫽ Imax ([S]/([S] ⫹ Km), where S represents either
nucleoside or protons. Unless otherwise indicated, Km values are expressed as mean ⫾ S.E. from fits to individual oocytes. Presteady-state
current measurements were recorded at the lowest gain possible to
avoid saturation of the amplifier response during the peak of the capacitance transient. For each oocyte, the charge movements carried by
the capacitive transient currents were calculated by time integration of
the substrate-dependent current after subtraction of steady-state current, which was defined as the current recorded during the last 10 ms
of the voltage pulse (16). Charge movements were plotted versus voltage
and fitted by least squares to the Boltzmann equation: Qtot ⫽ (1 ⫹
exp[e0z␦(Vm ⫺ V0.5)/kT]) ⫹ Qoffset, where Qtot is the total charge movement, V0.5 is the midpoint of the charge movement, Vm is the membrane
potential, z␦ is the product of the valence of the charge and apparent
fraction of the field sensed by that charge, Qoffset is the offset that
depended on the holding potential, e0 is the elementary charge, k is the
Boltzmann constant, and T is the absolute temperature. For comparisons among oocytes, charge movements were offset vertically by Qoffset
and normalized to the Qtot in the same oocytes.
Radiolabeled Nucleoside Flux—Oocytes expressing LdNT1.1 or
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FIG. 1. Substrate selectivity of the LdNT1 transport system. Oocytes were voltage-clamped at Vm ⫽ ⫺100 mV, and substrates (10 M) of
the LdNT1 transport system or other compounds were applied to the bath for the duration indicated by the bar. In each case, current recordings
from one oocyte are shown, but the experiment was repeated with a total of n oocytes. Currents from oocytes expressing LdNT1.2 (A, n ⬎ 6) and
LdNT1.1 (B, n ⬎ 6) or uninjected oocytes (C, n ⫽ 5) are shown. Adenine, inosine, guanosine, ADP, and ATP did not generate a current (A) in oocytes
injected with LdNT1.1 or LdNT1.2 cRNA (data not shown, n ⫽ 4).
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LdNT1.2 were incubated in wells containing either 10 M [3H]adenosine or [3H]uridine (⬃3 ⫻ 10⫺5 Ci/mmol; Amersham Biosciences) for
30 min. Oocytes were then washed for 20 s with Ringer’s buffer, transferred into a scintillation tube, solubilized in 1% SDS, and counted by
liquid scintillation spectrometry.
RESULTS

Electrogenic Nucleoside Transport—Inward currents were
observed in oocytes that were voltage-clamped at ⫺100 mV and
injected with LdNT1.2 cRNA after application of adenosine,
AMP, uridine, thymidine, or cytidine at a concentration of 10
M (Fig. 1A). No current was observed when the same concentration of inosine, guanosine, adenine, ADP, or ATP, was added
(Fig. 1A). In contrast, oocytes microinjected with LdNT1.1
cRNA exhibited an outward current in response to either adenosine or AMP but an inward current when the pyrimidine
nucleosides uridine, cytidine, and thymidine were applied (Fig.
1B). No currents were observed in uninjected oocytes in response to the application of any substrate of LdNT1 permeases
(Fig. 1C). When DPA (0.1% Me2SO), a potent inhibitor of mammalian nucleoside transporters (7), was superfused over oocytes expressing LdNT1.1 or LdNT1.2 cRNA, an outward current similar to that observed with adenosine or AMP for
LdNT1.1 was observed (Fig. 1, A and B). In contrast, DPA
application to uninjected oocytes induced a small inward current (⬃20% of the outward current observed after injection
with LdNT1.2 cRNA, Fig. 1B). In summary, the known substrates of LdNT1.1 and LdNT1.2, as well as AMP and DPA,
induced currents in each permease.
Although LdNT1.1 and LdNT1.2 differ in sequence by only 6
residues (4), an interesting distinction in the adenosine and
AMP response currents of these two transporters was observed.
At Vm ⫽ ⫺100 mV, adenosine and AMP generate outward
currents similar to that observed with DPA when applied to
LdNT1.1 (Fig. 1B). In LdNT1.2, however, a significant inward
current developed in response to 10 M adenosine and AMP
(Fig. 1A). In order to correlate the differences in the electrical
properties of LdNT1.1 and LdNT1.2 with the potential function
of these proteins as concentrative transporters, the elicited
current was plotted as a function of voltage (I/V curves) for
oocytes superfused with either 10 M adenosine or uridine (Fig.
2). The adenosine-dependent currents for LdNT1.1 were outward at hyperpolarized membrane potentials, reversed at a

membrane potential of ⬃⫺20 mV, and were inward at depolarized potentials (Fig. 2A), whereas the adenosine currents mediated by LdNT1.2 were inwardly rectifying (Fig. 2B). However, the shape of the LdNT1.2 current versus voltage curve for
adenosine exhibited a negative slope conductance at membrane
potentials more positive than Vm ⫽ ⫺10 mV. In contrast, 10 M
uridine triggered inward currents in both LdNT1.1 and
LdNT1.2.
The data in Fig. 2 were used to estimate molar charge to
substrate flux ratios for the two transporters. First, uptake of
[3H]adenosine and [3H]uridine over a 30 min time course was
measured for each permease using 5 oocytes (Fig. 2C). Using
the average resting membrane potential (RMP) measured for
these oocytes (LdNT1.1: RMP ⫽ ⫺53.0 ⫾ 5.0 mV; LdNT1.2:
RMP ⫽ ⫺27.0 ⫾ 0.6 mV), the integrated charge crossing the
membrane over the 30 min time course of the uptake assay was
calculated from the currents in the same group of oocytes
defined at each RMP by the curves in Fig. 2, A and B. The molar
amounts of charge thus calculated were divided by the molar
amounts of radiolabeled ligand that crossed the membrane
during the 30 min assay to estimate the charge to substrate
flux ratios. According to these calculations, LdNT1.1 countertransported 0.029 charges per molecule of adenosine and cotransported 0.13 charges per molecule of uridine. LdNT1.2
co-transported 0.0035 charges per molecule of adenosine and
co-transported 0.46 charges per molecule of uridine. These
non-integer charge to flux values clearly indicate that substrate flux is not tightly coupled to the total currents mediated
by LdNT1 transporters. An explanation for charge to flux ratios
significantly below unity is offered under “Discussion.” However, the charge to flux ratio of 0.46 for the uridine-induced
currents in LdNT1.2 suggests that there is a substantial coupling of transmembrane charge movement to substrate import.
pH Dependence of Adenosine-induced Steady-state Currents—To further investigate the origin of the currents observed in Figs. 1 and 2, and to determine whether they might
represent proton symport, the pH dependence of the steadystate adenosine-response currents was examined for LdNT1.1
and LdNT1.2. Oocytes expressing each permease were exposed
to voltage jumps from a holding potential of ⫺60 mV to a range
of command potentials. Currents elicited in the absence of
adenosine were then subtracted from those recorded in the
presence of 30 M adenosine, resulting in the current versus
time traces shown in Fig. 3A. At pH 6.5, 7.5, and 8.5 LdNT1.1
and LdNT1.2-expressing oocytes revealed an initial transient
capacitive or presteady-state current that then decayed to a
steady-state value. No currents were observed in uninjected
oocytes (data not shown, n ⬎ 5).
The steady-state adenosine response currents for LdNT1.2
were plotted as a current-voltage curve (Fig. 3B). Adenosine
induced an inward rectifying current at pH 6.5, which is consistent with an inward flux of protons that is coupled to import
of adenosine. Notably, the currents at pH 7.5 and 8.5 were
considerably smaller than at pH 6.5, again consistent with a
coupled flux of protons that experiences a smaller driving force
at increased external pH values. There were some differences
however in the shapes of the curves, with negative slope conductances at positive potentials at both pH 7.5 and 8.5.
In contrast, the shapes of the steady-state current-voltage
curves for LdNT1.1 (Fig. 3C) were more complex than those for
LdNT1.2. One notable difference between the two permeases is
that the adenosine-elicited currents for LdNT1.1 generally exhibited negative slope conductances and reversal potentials
that were shifted ⬃25 mV per unit change in external pH, in
contrast to LdNT1.2. These data suggest that a primary action
of adenosine in LdNT1.1 is to block a membrane conductance
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FIG. 2. LdNT1.1 and LdNT1.2 exhibit different electrogenic
properties. Currents induced by adenosine and uridine were measured for LdNT1.1 (A, n ⫽ 3) and LdNT1.2 (B, n ⫽ 3). Uptake of [3H]adenosine and [3H] uridine was also measured over a 30 min time
course for LdNT1.1 and LdNT1.2 (C, n ⫽ 5). The uptake observed in
LdNT1.1- and LdNT1.2-injected oocytes was between 21- and 177-fold
over the background uptake in uninjected oocytes. Data shown are
LdNT-specific uptake values.
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that is carried in part by protons. It is notable that in contrast
to the results at higher pH values, the outward current induced
by LdNT1.1 at pH 6.5 decreased again at potentials more
negative that ⫺60 mV and again became inward at potentials
more negative than ⬃⫺120 mV, resulting in an inverted Ushaped curve (Fig. 3C). These results suggest that at low pH,
LdNT1.1, like LdNT1.2, mediates an adenosine-coupled proton
symport process that gives rise to an inward current. This
substrate-coupled import of protons would be of the largest
magnitude at pH 6.5 and at the most polarized membrane
potentials, as demonstrated in Fig. 3B for the corresponding
current for LdNT1.2. The inverted U-shaped curve for LdNT1.1
at pH 6.5 could thus be explained by the additive combination
of the blockage of a proton leak current by adenosine, which
predominates above a membrane potential of ⫺60 mV, and an
adenosine-coupled proton symport current that becomes apparent below a membrane potential of ⫺60 mV.
To further define the proton dependence of LdNT1.2 steadystate currents, the adenosine concentration dependence of
these response currents was examined at Vm ⫽ ⫺100 mV and
at pH 6.5, 7.5, and 8.5 (Fig 4A). The magnitudes of the currents
elicited by adenosine concentrations ranging from 0.1–100 M
adenosine were greatest at pH 6.5 and lowest at pH 8.5. The
transporter affinity decreased and the maximal transport rate
increased with increasing proton concentrations. Thus from the

currents observed, a Km value of 1.00 ⫾ 0.09 M could be
calculated for LdNT1.2 at pH 7.5. At pH 6.5, the transporter
exhibited a Km value of 2.63 ⫾ 0.45 M and an Imax of 600 ⫾
26% greater than the Imax at pH 7.5. At pH 8.5, the Km was
0.50 ⫾ 0.08 M, and the Imax was 5.2 ⫾ 0.5% of its value at pH
7.5. In summary, the increase of adenosine-elicited currents in
LdNT1.2 at lower pH values further supports proton symport
as a mechanism for transport.
Lack of Sodium Dependence of Adenosine Uptake or Adenosine-induced Currents—The observation of electrogenic transport for these protozoan nucleoside permeases contrasts with
other members of the ENT family, which are equilibrative
permeases and not electrogenic (7). In contrast another family
of nucleoside transporters, the CNTs, are sodium-dependent
electrogenic active transporters (15). Consequently, whether
LdNT1.1- or LdNT1.2-mediated adenosine uptake might be
sodium dependent was also determined. Replacement of sodium in the bath with equimolar choline did not significantly
affect either LdNT1.1- or LdNT1.2-mediated adenosine uptake
(Fig. 4B). Furthermore, the LdNT1.2 transporter exhibited no
significant difference in either the affinity or maximal current
when sodium was replaced with choline (Fig. 4C). Indeed, replacement of sodium with choline did not affect adenosineinduced currents for LdNT1.2 at any adenosine concentration,
indicating that LdNT1.2 is not a sodium symporter.
Capacitive Gating Currents—As noted above (Fig. 3), application of voltage jumps to oocytes expressing LdNT1.1 or
LdNT1.2 induced adenosine-dependent presteady-state or
transient currents that decayed with exponential time constants of ⬍100 msec. For some transporters, such transient
currents have been linked to binding of a co-transported ion to
the permease (16). To determine whether the adenosineinduced transient currents could be explained by binding of
protons to the permeases, and could thus be useful for probing
interaction of protons with the transporters, the kinetic properties of these pre-steady-state currents were examined at sev-

Downloaded from http://www.jbc.org/ at UNIV OF MONTANA on October 9, 2019

FIG. 3. pH dependence of adenosine transport currents in
LdNT1.1 and LdNT1.2. Oocytes expressing LdNT1.1 and LdNT1.2
were voltage-clamped, and 30 M adenosine was applied to the bath at
pH 6.5, 7.5, and 8.5. Voltage steps were executed from a holding potential of ⫺60 mV to between ⫹60 and ⫺160 mV, and currents obtained in
the absence of adenosine were subtracted from currents recorded in the
presence of adenosine. A, representative families of adenosine response
currents at membrane potentials between ⫹60 and ⫺140 mV are
shown. Records of LdNT1.1 were low-pass filtered at 500 Hz. LdNT1.2
records were digitized at 1 kHz. The vertical scale bar is 100 nA for
LdNT1.1 and 400 nA for LdNT1.2. No adenosine response currents
were observed in uninjected oocytes (n ⬎ 6). The current-voltage relationships of the LdNT1.2 (B) and LdNT1.1 (C) adenosine response
currents at pH 6.5, 7.5, and 8.5 were plotted. Data represents normalized mean ⫾ S.E. (n ⫽ 3– 4).

FIG. 4. LdNT transporters are proton- but not sodium-dependent. A, different concentrations of adenosine were applied to voltageclamped oocytes expressing LdNT1.2 at pH 6.5, 7.5, and 8.5. Adenosine
dose responses at Vm ⫽ ⫺100 mV are shown; curves are least squares
fits of the data (normalized mean ⫾ S.E., n ⫽ 4 –5) to the MichaelisMenten equation with Km values of 2.63 ⫾ 0.45 M (pH 6.5), 1.00 ⫾ 0.09
M (pH 7.5), and 0.50 ⫾ 0.08 M (pH 8.5). B, [3H]adenosine uptake in
oocytes expressing LdNT1.1 and LdNT1.2 was not significantly different when sodium was completely replaced with choline during the assay
(n ⫽ 5). C, LdNT1.2 adenosine dose responses at Vm ⫽ ⫺100 mV in
sodium and choline-substituted recording solutions are shown; curves
are least squares fits of the data (normalized mean ⫾ S.E., n ⫽ 3) to the
Michaelis-Menten equation with Km values of 0.999 ⫾ 0.09 M (Na⫹),
1.09 ⫾ 0.06 M (choline⫹). The dose response in choline was fitted with
an normalized Imax of 1.1 ⫾ 0.1.
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eral proton concentrations by time integration of the currents
following the return of the clamped membrane to the holding
potential from a voltage step (Fig. 5). The transient charge
movement obeyed similar voltage dependences at pH 6.5, 7.5,
and 8.5 (Fig. 5A, n ⫽ 4). The total charge movement induced by
adenosine was similar at these pHs (Qtot (pH 6.5) is 35033 ⫾
3980 pC; Qtot (pH 7.5) is 44771 ⫾ 2883 pC; Qtot (pH 8.5) is
39179 ⫾ 1771 pC). The midpoint of the integrated current
voltage dependence is a measurement of the transporter’s affinity for the translocated charge (16). The midpoint of the
integrated transient current mediated by 30 M adenosine was
also found to be essentially independent of pH (V0.5 (pH 6.5) is
3.31 ⫾ 3.23 mV; V0.5 (pH 7.5) is ⫺9.53 ⫾ 3.33 mV; V0.5 (pH 8.5)
is ⫺4.93 ⫾ 2.53 mV). The transient current elicited by 30 M
adenosine also exhibited a similar slope to its voltage dependence at the three pHs examined, which implies that the translocated charge experiences the same fraction of the membrane
electric field under these conditions (slope (pH 6.5) is 60.90 ⫾
2.70 mV⫺1; slope (pH 7.5) is 81.88 ⫾ 3.59 mV⫺1; slope (pH 8.5)
is 74.40 ⫾ 4.00 mV⫺1) (17). The insensitivity of midpoint and
slope values to changes in pH implies that the capacitive transient current is not due to a proton binding event. Rather, it
may be a charge-moving conformational change in the transport protein.
To verify that the transient current elicited by adenosine was
associated with transporter function, the adenosine concentration dependence of the integrated capacitive current was examined (Fig. 5B). The magnitude of the capacitive current was
dependent upon adenosine concentration in a dose-dependent
manner, and the apparent affinity of the transporter for adenosine (Km is 1.35 ⫾ 0.11 M) when measured in this way was
similar to that derived from analysis of the steady-state cur-

FIG. 6. DPA blocks a proton leak in LdNT1.1 and LdNT1.2. 30
M DPA was applied to oocytes expressing LdNT1.1 or LdNT1.2, and
uninjected oocytes at pH 6.5, 7.5, and 8.5. A, representative current
families of the DPA response current at pH 7.5 are shown. Cells were
voltage-clamped at ⫺50 mV, and the membrane potential was stepped
to between ⫹60 and ⫺140 mV. Data are subtractions of control currents
from currents recorded during dipyridamole application. B, currentvoltage relations for the LdNT1.1-mediated current induced by dipyridamole at pH 6.5, 7.5, and 8.5 are shown. The reversal potential (Vrev)
of the response current is pH-dependent (n ⫽ 3). Vrev ⫽ ⫺35 ⫾ 6 mV (pH
6.5), ⫺55 ⫾ 8 mV (pH 7.5), ⫺96 ⫾ 7 mV (pH 8.5). C, current-voltage
relations for LdTN1.2-mediated currents (n ⫽ 3). Vrev ⫽ ⫺16 ⫾ 3 mV
(pH 6.5), ⫺34 ⫾ 3 mV (pH 7.5), ⫺57 ⫾ 3 mV (pH 8.5). D, DPA response
currents in uninjected oocytes (n ⫽ 3).

rents (Km is 1.00 ⫾ 0.09 M, Fig. 4). These results imply that
the pre-steady-state currents reflect transporter function.
It is possible to estimate the charge transfer rate of the
transporter by dividing the steady-state current through the
transporter (I, pC/sec) by the total number of elementary
charges blocked by adenosine (Q/z␦, pC) and assuming a charge
to flux stoichiometry of 1:1 (16). The charge transfer rate was
calculated at pHs between 5.5 and 8.5 (Fig. 5C). Performing
this calculation at pH 7.5 revealed that the transporter moves
0.7 ⫾ 0.05 times per second through the membrane at ⫺100
mV. The proton dose dependence of the transporter’s charge
transfer rate was fitted with a proton affinity of 0.62 ⫾ 0.05 M,
and the maximal cycling rate was found to be 10.4 ⫾ 0.2 per
sec.
DPA Blocks a Tonic Proton Leak through LdNT1 Transporters—DPA is a high affinity antagonist of mammalian adenosine transporters (7) but does not significantly inhibit nucleoside transporters from parasitic protozoa (1). Despite its failure
to significantly inhibit the Leishmania permeases, DPA activates a current in LdNT-expressing oocytes (Fig. 1, A and B).
To further characterize the effect of DPA on these transporters,
the transmembrane currents recorded prior to DPA application
were subtracted from currents recorded during DPA application revealing a current in LdNT1-expressing cells that was not
observed in uninjected oocytes (Fig. 6A). The DPA-induced
currents in LdNT1.1 and LdNT1.2 were linear and reversible,
and they were outward at more negative membrane potentials
(Fig. 6, B and C). The LdNT1-mediated currents saturated with
respect to the DPA concentration (Km is 35 ⫾ 10 M in LdNT1.2
at Vm ⫽ ⫺100 mV; data not shown, n ⫽ 4). In contrast, the
smaller current that was present in uninjected oocytes was
inward and did not reverse (Fig. 6D),
Similar to the behavior of the transporter current blocked by
adenosine, the reversal potential of the DPA-elicted currents
was observed to shift to more positive values as the extracellular concentration of protons was increased, suggesting that
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FIG. 5. Kinetics of the transient current blocked by adenosine
transport in LdNT1.2. A, a family of subtracted current records in a
representative LdNT1.2-expressing oocyte showing the voltage dependence of the capacitative transient current induced by 30 M adenosine
at pH 7.5 is shown (inset). A voltage command pulse to ⫺60 mV was
executed from a 0.250 s pre-pulse of from ⫹60 to ⫺160 mV (20-mV
increments). Integrated charge movements from cells expressing
LdNT1.2 at pH 6.5, 7.5, and 8.5 were normalized to the Qtot and fitted
by least squares to a Boltzmann function (n ⫽ 5). B, the adenosine
concentration dependence of the integrated charge movements was
fitted to the Michaelis-Menten equation with a Km of 1.35 ⫾ 0.11 M. C,
the charge transfer rate of the LdNT1.2 transporter was calculated by
adjusting the Qtot by z␦, and then dividing the steady-state current
induced by 30 M adenosine at Vm ⫽ ⫺100 mV by the adjusted Qtot. The
proton concentration dependence of the charge transfer rate was fitted
to the Michaelis-Menten equation with a Km of 0.62 ⫾ 0.05 M and Vmax
of 10.36 ⫾ 0.23 per second.
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this current is carried substantially by protons (Fig. 6, B and
C). A quantitative analysis of the reversal potential pH dependence is precluded by the DPA-induced current in uninjected
oocytes (Fig. 6D).
AMP Induces Currents for LdNT1.1 and LdNT1.2—The observation that AMP was able to elicit currents in oocytes microinjected with either LdNT1.1 or LdNT1.2 cRNA (Fig. 1) was
surprising in view of the negative charge of the nucleotide and
the fact that nucleotides typically are not taken up by intact
eukaryotic cells. To further investigate this phenomenon, we
measured current-voltage curves for AMP-induced currents for
LdNT1.2 (Fig. 7), the permease that elicited inward directed
currents with this ligand. For LdNT1.2 the maximal AMPinduced current at Vm ⫽ ⫺100 mV was 20.1% of the maximal
current induced by a saturating (30 M) concentration of adenosine in the same oocytes (Fig. 7A). The AMP response current
in LdNT1.2 was saturable with respect to AMP, and its concentration dependence exhibited an apparent affinity of 9 ⫾ 3
M (Fig. 7B). The shapes of the AMP and adenosine response
current-voltage relationships are qualitatively similar at pH
7.5 (compare Fig. 7A to Fig. 3B). It does not appear that the
AMP-induced current could be ascribed to adenosine contamination because the purity of the AMP was verified by high
performance liquid and thin layer chromatography (data not
shown). Furthermore, when [3H]AMP was applied to LdNT1.2expressing oocytes, the radiolabel was taken up robustly by the
oocytes, but no significant amount of [3H]adenosine was liberated into the supernatant.2 Hence, the AMP-induced currents
cannot be ascribed to hydrolysis of AMP that liberates free
adenosine into the medium followed by uptake of this liberated
adenosine by the permease. The origin of these AMP-induced
currents is currently under investigation.
The LdNT2 Inosine-Guanosine Permease Is Also Electro2

S. M. Landfear, unpublished data.

genic—The other nucleoside transporter of L. donovani,
LdNT2, mediates the uptake of inosine and guanosine, is also a
member of the ENT family, and exhibits 33% sequence identity
to LdNT1.1 (5). Oocytes injected with LdNT2 cRNA were also
shown to elicit inward response currents to the application of
ligands. Inosine and guanosine, but not adenosine or thymidine, mediated inward rectifying currents in a voltage-dependent fashion (Fig. 8A). LdNT2 also mediated a reversible DPAinduced outward current at negative membrane potentials,
similar to that observed for LdNT1.1 and LdNT1.2. Neither
inosine, guanosine, adenosine, nor thymidine induced a current
in uninjected oocytes, although 10 M DPA elicited a small
inward current (Fig. 8B). The induction of inward rectifying
currents specifically by substrates of the LdNT2 permease implies that this transporter also couples the symport of protons
to nucleosides, much as demonstrated above for the LdNT1.2
carrier. The outward directed currents elicited by DPA suggest
that this compound blocks a constitutive leak current in
LdNT2, in a manner similar to that observed for LdNT1.1 and
LdNT1.2 (Fig. 6).
DISCUSSION

We have shown that adenosine/pyrimidine nucleoside transport through the LdNT1 transporters is associated with the
activation of transmembrane currents. The magnitudes of the
currents mediated by LdNT1.2 and the substrate fluxes mediated by both LdNT1.1 and LdNT1.2 were dependent on the
proton, but not the sodium, gradient, strongly suggesting that
these proteins are proton/nucleoside symporters. Unlike the
Leishmania proton/myo-inositol symporter MIT, which transports myo-inositol with a charge to flux ratio of 1 (13), LdNT1
did not mediate substrate flux that was tightly coupled to total
charge translocation. Although LdNT1.1 and LdNT1.2 are very
similar in sequence, they exhibit striking differences with respect to their electrogenic properties, most notably that adenosine strongly blocks a leak current in LdNT1.1, whereas adenosine induces an inward proton current in LdNT1.2. It is likely
that the adenosine blockage of the leak current in LdNT1.1
obscures an inward directed adenosine-coupled proton current
similar to that observed in LdNT1.2. In fact, the inward directed current observed for LdNT1.1 at pH 6.5 below a trans-
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FIG. 7. Kinetics of AMP transport in LdNT1.2. Oocytes expressing LdNT1.2 were voltage-clamped, and different concentrations of
adenosine 5⬘-monophosphate were superfused into the recording chamber. A, the response currents at each voltage and at different concentrations of AMP were plotted (n ⫽ 3). B, at ⫺100 mV, the concentration
dependence of the current response was fitted to the Michaelis-Menten
equation with a Km of 9.1 ⫾ 3.2 M. Data represent normalized mean ⫾
S.E.

FIG. 8. Electrogenic nucleoside transport in LdNT2. Nucleosides and DPA were bath-applied to voltage-clamped LdNT2-expressing
(A) and uninjected (B) oocytes at a concentration of 10 M. Steps of the
membrane potential to between ⫹10 and ⫺110 mV were executed, and
the currents elicited at each voltage are indicated. Data are represented
as mean ⫾ S.E. (n ⫽ 4).
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other polymorphisms include M107I (between TMD2 and
TMD3) and T160A (between TMD4 and TMD5), which are
located within predicted hydrophilic loops of the permeases.
Mutational analysis outside the scope of this manuscript will
be needed to evaluate the role of each polymorphism on the
kinetic and electrophysiological differences between LdNT1.1
and LdNT1.2.
Our analysis of the transporters responsible for nucleoside
transport in L. donovani, LdNT1.1, LdNT1.2, and LdNT2, has
demonstrated that these proteins couple the large proton electrochemical gradient available to the parasites to nucleoside
uptake. Purine uptake is vital to the survival of the parasites,
as they are incapable of purine biosynthesis, and the ability of
the parasite to concentrate essential purines from the extracellular medium may thus provide an evolutionary advantage by
promoting its survival within both the insect vector and/or the
vertebrate host. The parasite nucleoside transporters studied
here exhibit ⬃30% identity at the amino acid sequence level
with members of the mammalian equilibrative nucleoside
transporter family. Since LdNT1.1, LdNT1.2 and LdNT2 are
apparently proton symporters, it now appears that some members of the ENT family are concentrative permeases. This conclusion is also consistent with previous studies performed on
transport of nucleosides by intact procyclic forms of the related
protozoan Trypanosoma brucei, in which the dependence of
nucleoside transport upon the proton electrochemical gradient
across the parasite plasma membrane strongly suggested proton symport as a mechanism of active transport (20). Similar
studies in which the ENT1 (At) permease from Arabidopsis
thaliana was expressed in yeast also strongly suggest that this
permease is a proton symporter (21). It is possible that relatively few changes in amino acid sequence determine whether
a nucleoside transporter of this family functions as a concentrative or equilibrative permease. However, the extensive differences in sequence between equilibrative and concentrative
members of the ENT family make it difficult to predict which
residues may be required for proton symport and suggest that
extensive structure-function studies will likely be required to
elucidate determinants of active transport.
The ability of the nucleotide AMP to induce currents in
LdNT1.1 and LdNT1.2 that are very similar to those induced
by adenosine, as well as the ability of radiolabel from [3H]AMP
to enter LdNT1.1 or LdNT1.2-expressing oocytes, is intriguing,
as these anionic metabolites are thought not to be transported
across the plasma membranes of eukaryotic cells. We are currently pursuing further studies to determine the nature of the
interaction of AMP with the LdNT1.1 and LdNT1.2 permeases.
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membrane voltage of ⫺120 mV (Fig. 3C) is likely to be such a
transport-coupled current that overcomes the block of the leak
current at this lower pH value and more negative membrane
potential. Thus the essential difference between the two permeases may be that adenosine effects a more robust block of
the leak current in LdNT1.1 compared with LdNT1.2.
We have also shown that LdNT1 transporters mediate a
constitutive proton conductance that is blocked by the compound DPA. Unlike the mammalian ENTs, the Leishmania
nucleoside transporters are not significantly inhibited by DPA
at concentrations that obliterate transport by mammalian
ENTs (2), and thus the precise nature of the interaction between this compound and the LdNTs is not clear. Nonetheless
the ability of DPA, which is very lipophilic and known to affect
the entry of many structurally unrelated compounds into mammalian cells (18, 19), to block the constitutive proton leak is
instructive, as it likely reflects a similar block of this leak
current that is induced by interaction of substrates with the
LdNT1 permeases.
We hypothesize that part of the reason charge translocation
appears to be loosely coupled to substrate flux in LdNT1.1 and
LdNT1.2 is that adenosine transport blocks the constitutive
proton conductance in a similar manner to DPA. By summing
a linear current with a pH-dependent reversal potential such
as the one observed upon application of DPA (Fig. 6, B and C)
and a pH-dependent inwardly rectifying transport current such
as that observed after application of adenosine to LdNT1.2 at
pH 6.5 (Fig. 3B), it is possible to generate current-voltage
curves with shapes corresponding to the adenosine response
current-voltage curves. This hypothesis is supported by the
observation that, while lower pH increases the relative contribution of inward adenosine response current at negative potentials in LdNT1.1, it also shifts the reversal potential of the
current-voltage curve to more positive potentials (Fig. 3C), as
would be expected for a current that represents blockage of a
proton leak. The presence of this blocked proton conductance
would cause our calculations of the charge to flux ratio to be
significant underestimates of the actual value, especially when
the measurements are made at the resting potentials of the
oocytes (between ⫺53 and ⫺27 mV) rather than at highly
polarized membrane potentials that favor the influx of protons
that are coupled to adenosine transport. In summary, the
blockage of a constitutive proton leak by substrates complicates
the estimation of charge to substrate flux ratios for these protozoan nucleoside transporters. However, this constitutive leak
is blocked less efficiently in LdNT1.2 than in LdNT1.1, and
uridine blocks this leak less effectively in both transporters
compared with adenosine (Fig. 2). Consequently, the charge to
flux ratio calculated for uridine in LdNT1.2 (0.46 charges per
molecule) is probably the estimate that most closely reflects the
value for proton symport coupled to a substrate. Hence, substrates appear to mediate the import of at least ⬃0.5 charge
units per molecule.
LdNT1.1 and LdNT1.2 differ by only 6 amino acid residues in
sequence, and three of these polymorphisms are located on the
extreme COOH termini of the proteins. Despite the high degree
of identity, these transporters exhibit different affinities for the
substrates adenosine and uridine (4) and mediate different
currents during adenosine and AMP transport. The COOHterminal residues are the uncharged ATY in LdNT1.1 compared with the highly charged ERH in LdNT1.2. While these
sequences could be important in determining the distinct electrogenic properties of the proteins, perhaps a more likely residue for the observed differences is P43 in LdNT1.1. This proline
is a serine in LdNT1.2, and it is the only polymorphism that
lies within a predicted transmembrane domain (TMD1). The
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